Abstract
Although patient self-management (PSM) of oral anticoagulation with vitamin K antagonists is recommended for patients requiring long-term anticoagulation, important aspects are still unclear. Using data from a large international survey (n = 15 834; median age 72 years; 30·1% female), we studied predictors of poor anticoagulation control (percentage of International Normalized Ratio values within therapeutic range below 75%) and developed a simple prediction model. The following variables were identified as risk factors for poor anticoagulation control and included in the final model: higher intensity of therapeutic range (odds ratio [OR] on every level 1·9; 95% confidence interval [CI] 1·8–2·0), long intervals between measurements (>14 d; 1·5; 95% CI 1·3–1·7), female sex (OR 1·3; 95% CI 1·2–1·4), and management other than PSM (OR 1·4; 95% CI 1·2–1·6). At a threshold of 0·2 (at least one variable present), the model predicted poor anticoagulation control with a sensitivity of 85·3% (95% CI: 84·0, 86·4) and a specificity of 28·5% (27·6, 29·5). The area under the receiver operated characteristic curve was 0·65. Using the proposed prediction model, physicians will be able to identify patients with a low chance of performing well, considering additional training, regular follow-up, or adjustment of therapeutic ranges.
| Original language | English |
|---|---|
| Pages (from-to) | 677-685 |
| Number of pages | 9 |
| Journal | British Journal of Haematology |
| Volume | 175 |
| Issue number | 4 |
| DOIs | |
| State | Published - Nov 1 2016 |
ASJC Scopus Subject Areas
- Hematology
Keywords
- International Normalized Ratio
- anticoagulant administration/dosage
- drug monitoring
- self care
- vitamin K antagonists/inhibitors
- Prognosis
- Administration, Oral
- Humans
- Middle Aged
- Male
- Treatment Outcome
- Blood Coagulation/drug effects
- Anticoagulants/administration & dosage
- Aged, 80 and over
- Blood Coagulation Tests
- Female
- ROC Curve
- Surveys and Questionnaires
- Aged
- Self Care
- Vitamin K/antagonists & inhibitors
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS